Schulert Lab

Publications

Romankevych, I; Sproles, A; Do, T; Auld, L; Sabit, T; Chhaing, R; Baker, E; Kumar, A; Trapnell, B; Carey, B; Brewington, JJ; Towe, C; Grom, A; Schulert, G. Distinct cytokine and chemokine alterations in bronchoalveolar fluid from patients with systemic juvenile idiopathic arthritis associated lung disease (SJIA-LD). Arthritis Research & Therapy. 2026.

Eloseily, E; Baker, JE; Schulert, G; Grom, A. Dr. Eloseily et al reply. Journal of Rheumatology. 2026.

Vega-Fernandez, P; Avar-Aydin, PO; Rogers, K; Lovell, DJ; Huggins, J; Grom, A; Brunner, HI; Schulert, GS; Angeles-Han, ST; Altaye, M; Cassedy, A; Meyers, AB; Ting, TV. Validation of the Pediatric Arthritis Ultrasound Scoring System for the Elbow, Wrist, and Finger Joints in Children With Juvenile Idiopathic Arthritis. Arthritis Care and Research. 2026; 78(7):905-913.

Eloseily, E; Romankevych, I; Sabit, T; Berklite, L; Ranganathan, S; Rosen, P; Henrickson, M; Huggins, J; Schulert, G; Grom, A. Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Journal of Rheumatology. 2026; 53(6):669-678.

Gorevic, PD; Niewold, TB; Aksentijevich, I; Pfeffer, G; Guitart, J; Schulert, GS; Hegde, M; Bowler, R; Gibson, G; Yao, Q. Challenging traditional classifications: Gene penetrance in genetically transitional disease. Genes and Diseases. 2026; 102334.

Matt, MG; Fuehner, S; Do, T; Schleifenbaum, S; Chiang, S; Marsh, R; Wouters, C; Matthys, P; Gouwy, M; Foell, D; Brown, KL; Cabral, DA; Schulert, G; Kessel, C. Speaking the same language: international cross-validation of emerging biomarkers for juvenile idiopathic arthritis and Still's Disease. Pediatric Rheumatology. 2026; 24(1).

Rogani, G; Kessler, H; Mehta, B; Baker, E; Leavis, H; Vastert, S; Schulert, G. Pathogenic and genetic landscape of Still's disease across ages, with new insights into age-related IL-18 patterns. Arthritis Research & Therapy. 2026; 28(1).

Soulsby, WD; Boscardin, J; Knight, A; Horton, DB; Toupin-April, K; Von Scheven, E. Cumulative Social Disadvantage and Disease Activity in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study. Arthritis Care and Research. 2026.

Garrison, WJ; Willmering, MM; Masokano, BI; Rai, S; Daou, AW; Roach, DJ; Morgan, EM; Woods, JC; Cleveland, ZI; Gecili, E; Schulert, GS; Grom, AA; Towe, CT; Walkup, LL. Characterization of Pulmonary Dysfunction in Systemic Juvenile Idiopathic Arthritis Using Xenon and Proton MRI. Pediatric Pulmonology. 2026; 61(4):e71613.

Rife, E; Zhai, G; Altaye, M; Andringa, J; Brunner, HI; Canna, S; Henderson, LA; Kimura, Y; Lieberman, SM; Riskalla, M; Towe, C; Vogel, T; Wobma, H; Schulert, G. Reliability and Construct Validity of the Physician's Global Assessment of Lung Disease in Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease. ACR Open Rheumatology. 2026; 8(3):e90006.

King, C; Jankowski, M; Coghill, R; Chidambaran, V; Brunner, H; Schulert, G; Ogbu, E; Zwolski, C; Wagner, M; Andorf, S; Huang, B; Kashikar-Zuck, S. 399 Biopsychosocial Risk Influences on Development and Generation of Early-onset Pain: The BRIDGE Pain Study Protocol. Journal of Pain. 2026; 41:106046.

Hirabayashi, K; Lorman, V; Wuller, S; Aragon, LV; Jhaveri, R; Jain, N; Leikauf, JE; Muszynski, JA; Martinez, AT; Higginbotham, M; Tedla, YG; Bailey, LC; Forrest, CB; Rao, S. Evaluation of steroids for acute COVID in the prevention of long COVID in children: An EHR and pediatric cohort study from the RECOVER Initiative. PLoS ONE. 2026; 21(6):e0350888.

Eloseily, E; Riordan, ME; Mahmoud, I; Clark, A; Chang, M-L; Russell, A; Natter, M; Thornton, S; Canna, S; Co, DO; Deguzman, M; Kimura, Y; Schulert, GS. Baseline Clinical Features and Biomarker Profiles of the Childhood Arthritis and Rheumatology Research Alliance Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease Cohort. Arthritis Care and Research. 2025.

Schulert, GS. Update on new autoinflammatory disorders from the 2024 Pediatric Rheumatology European Society Congress. Pediatric Rheumatology. 2025; 23(1):107.

Correll, C; Burciu, A; Bansal, A; Dennos, A; Narayanswamy, D; Aubrun, E; Schanberg, LE; Yuhan, L; Schneider, R; Balevic, S; Kimura, Y; Beukelman, T. Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. Pediatric Rheumatology. 2025; 23(1):105.

Ringold, S; Ong, M-S; Tomlinson, G; Natter, MD; Schanberg, LE; Del Gaizo, V; Feldman, BM; Murphy, KL; Kimura, Y. Three-Year Outcomes and Latent Class Trajectory Analysis of the Childhood Arthritis and Rheumatology Research Alliance Polyarticular JIA Consensus Treatment Plans Study. Arthritis & Rheumatology. 2025; 77(10):1433-1441.

Mannion, ML; Aswani, MS; Hearld, KR; Smitherman, EA; Timmerman, L; Curtis, JR. Disease activity at two consecutive registry visits and subsequent medication escalation for patients with juvenile idiopathic arthritis in the CARRA registry. Pediatric Rheumatology. 2025; 23(1):77.

Nguyen, K; Yasin, S; Fall, N; Grom, AA; Brunner, HI; Towe, C; Schulert, GS. Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis. Pediatric Rheumatology. 2025; 23(1):74.

Sandborg, CI; Schulert, GS; Kimura, Y. Juvenile Idiopathic Arthritis. New England Journal of Medicine. 2025; 393(2):162-174.

Macaraeg, M; Sood, A; Guner, ME; Guner, MK; Schulert, G; Mahajan, VB; Utz, VM; Angeles-Han, ST. Genetic Inflammatory Diseases with Ocular Involvement. In: Genetic Diseases of the Eye. Oxford University Press (OUP); 2025:1070-1091.

Maccora, I; Altaye, M; Greis, KD; Brunner, HI; Duell, A; Haffey, WD; Nguyen, T; Quinlan-Waters, M; Schulert, GS; Sproles, A; Utz, VM; Thornton, S; Angeles-Han, ST. Candidate Tear-Based Uveitis Biomarkers in Children with JIA Based on Arthritis Activity and Topical Corticosteroid Use. Ocular Immunology and Inflammation. 2025; 33(4):603-612.

Macaraeg, M; Baker, E; Handorf, E; Matt, M; Baker, EK; Brunner, H; Grom, AA; Henrickson, M; Huggins, J; Zhang, W; Lee, P; Marsh, R; Schulert, GS. Clinical, Immunologic, and Genetic Characteristics in Patients With Syndrome of Undifferentiated Recurrent Fevers. Arthritis & Rheumatology. 2025; 77(5):596-605.

Wendroth, R; Paisley, A; Marsh, R; Schulert, G; Wikenheiser-Brokamp, KA; Burg, G. Lung Disease in Systemic Juvenile Idiopathic Arthritis: An Atypical Path to Diagnosis. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a7865-a7865.

Cook, E; Schulert, G; Grom, A; Towe, C; Burg, G; Marsh, R; Chandra, S. Experience with T Cell–Depleted Allogeneic HSCT for Refractory sJIA Associated with Lung Disease. Journal of Human Immunity. 2025; 1(CIS2025).

Matt, MG; Drozdov, D; Bendstrup, E; Glerup, M; Hauge, E-M; Masmas, T; Schneider, EC; Zeilhofer, UB; Abu-Arja, RF; Driest, KD; Chandra, S; Grom, A; Schulert, GS; Marsh, RA. Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study. The Lancet Rheumatology. 2025; 7(4):e243-e251.

Baldo, F; Erkens, RGA; Mizuta, M; Rogani, G; Lucioni, F; Bracaglia, C; Foell, D; Gattorno, M; Jelusic, M; Anton, J; Ruperto, N; Swart, JF; Vastert, S; Minoia, F. Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project. Rheumatology. 2025; 64(1):32-44.

Soulsby, WD; Olveda, R; He, J; Berbert, L; Weller, E; Barbour, KE; Greenlund, KJ; Schanberg, LE; Von Scheven, E; Hersh, A; Son, MBF; Chang, J; Knight, A. Racial Disparities and Achievement of the Low Lupus Disease Activity State: A CARRA Registry Study. Arthritis Care and Research. 2025; 77(1):38-49.

Randell, RL; Schanberg, LE; Beard, C; Phillips, T; Hornik, CP; Cohen-Wolkowiez, M; Balevic, SJ. Effect of an Electronic Pill Bottle on Hydroxychloroquine Adherence in Pediatric Lupus: Results of a Novel Direct-to-Family Pilot Trial. ACR Open Rheumatology. 2025; 7(1):e11780.

Henderson, LA; Abraham, RS; Ahmed, A; Blount, L; Canna, SW; Chaimowitz, NS; Chandrakasan, S; Coates, B; Connelly, JA; Cooper, MA; Vogel, T; Walkovich, K; Zinter, MS; Behrens, EM. Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementation. Frontiers in Immunology. 2025; 16:1519955.

Wuller, S; Singer, NG; Lewis, C; Karlson, EW; Schulert, GS; Goldman, JD; Hadlock, J; Arnold, J; Hirabayashi, K; Stiles, LE; Johnson, SG; Stroebel, S; Wallace, ZS; Costenbader, KH. Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohorts. PLoS ONE. 2025; 20(6):e0324513.

Maccora, I; Ebert, JJ; Schulert, GS; Quinlan-Waters, M; Duell, A; Huggins, JL; Sapp, CC; Nguyen, T; Srivastava, SK; Sood, AB; Angeles-Han, ST. Treatment and Visual Outcomes in Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy: A Cohort Study. Ocular Immunology and Inflammation. 2024; 32(10):2441-2448.

Gulick, RM; Pau, AK; Daar, E; Evans, L; Gandhi, RT; Tebas, P; Ridzon, R; Masur, H; Lane, HC; Adimora, AA; Waghmare, A; Wolfe, C; Yazdany, J; Aberg, J. National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned. Annals of Internal Medicine. 2024; 177(11):1547-1557.

Brunner, HI; Akikusa, JD; Al-Abadi, E; Bohnsack, JF; Boteanu, AL; Chedeville, G; Cuttica, R; De La Pena, W; Jung, L; Kasapcopur, O; Liu, S; Martini, A; Lovell, DJ; Ruperto, N. Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study. Annals of the Rheumatic Diseases. 2024; 83(11):1561-1571.

Chang, MH; Barbar-Smiley, F; Akoghlanian, S; Drew, J; Angeles-Han, ST; Quinlan-Waters, M; Bohnsack, JF; Cooper, AM; Edelheit, B; Twachtman-Bassett, J; Lerman, MA; Nanda, K; Rabinovich, CE; Lo, MS. Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research. Pediatric Rheumatology. 2024; 22(1):88.

Carol, HA; Mayer, AS; Zhang, MS; Dang, V; Varghese, J; Martinez, Z; Schneider, C; Baker, JE; Tsoukas, P; Behrens, EM; Schulert, G; Lee, P; Kernan, KF; Canna, SW. Hyperferritinemia Screening to Aid Identification and Differentiation of Patients with Hyperinflammatory Disorders. Journal of Clinical Immunology. 2024; 45(1):4.

Correia Marques, M; Ombrello, MJ; Schulert, GS. New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis. Expert Review of Clinical Immunology. 2024; 20(9):1053-1064.

Lovell, DJ; Tzaribachev, N; Henrickson, M; Simonini, G; Griffin, TA; Alexeeva, E; Bohnsack, JF; Zeft, A; Horneff, G; Vehe, RK; Simon, TA; Martini, A; Brunner, HI; Ruperto, N. Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry. Rheumatology. 2024; 63(SI2):SI195-SI206.

Mannion, ML; Amin, S; Balevic, S; Chang, M-L; Correll, CK; Kearsley-Fleet, L; Hyrich, KL; Beukelman, T. Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non-Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular-Course Juvenile Idiopathic Arthritis. Arthritis Care and Research. 2024; 76(8):1090-1098.

Brunner, HI; Schulert, GS; Sproles, A; Thornton, S; Cornejo, GV; Antón, J; Cuttica, R; Henrickson, M; Foeldvari, I; Kingsbury, DJ; Lovell, DJ; Martini, A; Ruperto, N; Grom, AA. S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis. Arthritis Research & Therapy. 2024; 26(1):125.

Huang, Y; Sompii-Montgomery, L; Patti, J; Pickering, A; Yasin, S; Do, T; Baker, E; Gao, D; Abdul-Aziz, R; Behrens, EM; Ting, T; Grom, AA; Towe, C; Schulert, GS. Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease. Arthritis Care and Research. 2024; 76(3):328-339.

Grom, AA; Canna, SW; Abu-Arja, RF; Sinha, R; Peixoto, L; Cannizzaro, E; Chandrakasan, S; Driest, K; Marsh, R; Neven, B; Schulert, G; Silva, JMF; Wall, D; Zeilhofer, U. Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe. Pediatric Rheumatology. 2024; 21(Suppl 1):86.

Schulert, G; Vastert, SJ; Grom, AA. The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA. Pediatric Rheumatology. 2024; 21(Suppl 1):87.

Erkens, RGA; Calis, JJA; Verwoerd, A; De Roock, S; Ter Haar, NM; Den Engelsman, G; Van Der Veken, LT; Ernst, RF; Van Deutekom, HWM; Pickering, A; Schulert, GS; Grom, AA; Van Loosdregt, J; Vastert, SJ. Recombinant Interleukin-1 Receptor Antagonist Is an Effective First-Line Treatment Strategy in New-Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA-DRB1 Background and IL1RN Variants. Arthritis & Rheumatology. 2024; 76(1):119-129.

Schulert, GS; Zhang, K. Genetics of Acquired Cytokine Storm Syndromes : Secondary HLH Genetics. Advances in Experimental Medicine and Biology. 2024; 1448:103-119.

Nazzar, S; Moorthy, L; Tousseau, J; Lapidus, S; Mansfield, L; Twilt, M; Schulert, G; Gutierrez, M; Angevare, S; Durrant, K; Dedeoglu, F. Effects of the COVID-19 Pandemic in Patients with Systemic Autoinflammatory Diseases. An international survey. Medical Research Archives. 2024; 12(10).

Graef, ER; Mehta, P; Schulert, GS; Sparks, JA; Kim, AHJ. COVID-19 and Rheumatic Disease. In: Firestein Kelley S Textbook of Rheumatology 2 Volume Set. 2024:2083-2094.e5.

Rao, S; Jing, N; Liu, X; Lorman, V; Maltenfort, M; Schuchard, J; Wu, Q; Tong, J; Razzaghi, H; Mejias, A; Christakis, DA; Bailey, LC; Forrest, CB; Chen, Y. Spectrum of severity of multisystem inflammatory syndrome in children: an EHR-based cohort study from the RECOVER program. Scientific Reports. 2023; 13(1):21005.

Verweyen, EL; Thakkar, K; Dhakal, S; Baker, E; Chetal, K; Schnell, D; Canna, S; Grom, AA; Salomonis, N; Schulert, GS. Population-level single-cell genomics reveals conserved gene programs in systemic juvenile idiopathic arthritis. Journal of Clinical Investigation. 2023; 133(22).

Woo, JMP; Simmonds, F; Dennos, A; Son, MBF; Lewandowski, LB; Rubinstein, TB. Health Equity Implications of Missing Data Among Youths With Childhood-Onset Systemic Lupus Erythematosus: A Proof-of-Concept Study in the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis Care and Research. 2023; 75(11):2285-2294.

Schulert, GS; Kessel, C. Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis. Rheumatic Disease Clinics of North America. 2023; 49(4):895-911.

Towe, C; Grom, AA; Schulert, GS. Diagnosis and Management of the Systemic Juvenile Idiopathic Arthritis Patient with Emerging Lung Disease. Paediatric Drugs. 2023; 25(6):649-658.

Shakoory, B; Geerlinks, A; Wilejto, M; Kernan, K; Hines, M; Romano, M; Piskin, D; Ravelli, A; Sinha, R; Aletaha, D; Goldbach-Mansky, R; De Benedetti, F; Marsh, RA; Canna, SW. The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS). Arthritis & Rheumatology. 2023; 75(10):1714-1732.

Shakoory, B; Geerlinks, A; Wilejto, M; Kernan, K; Hines, M; Romano, M; Piskin, D; Ravelli, A; Sinha, R; Aletaha, D; Goldbach-Mansky, R; De Benedetti, F; Marsh, RA; Canna, SW. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Annals of the Rheumatic Diseases. 2023; 82(10):1271-1285.

Rai, S; Schulert, GS; Towe, C. New developments related to lung complications in pediatric rheumatic disease. Current Opinion in Rheumatology. 2023; 35(5):273-277.

Chen, L; Mamutova, A; Kozlova, A; Latysheva, E; Evgeny, F; Latysheva, T; Savostyanov, K; Pushkov, A; Zhanin, I; Raykina, E; Nigrovic, PA; Shcherbina, A; Alexeeva, E; Lee, PY. Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2. Journal of Allergy and Clinical Immunology. 2023; 152(3):771-782.

Roberts, JE; Williams, K; Dallas, J; Eckert, M; Huie, L; Smitherman, E; Soulsby, WD; Zhao, Y; Son, MBF. Insurance Status and Tumor Necrosis Factor Inhibitor Initiation Among Children With Juvenile Idiopathic Arthritis in the CARRA Registry. Journal of Rheumatology. 2023; 50(8):1047-1057.

Heshin-Bekenstein, M; Baron, S; Schulert, G; Shusterman, A; Fidel, V; Ben-Shahar, Y; Shukrun, R; Binenbaum, Y; Elhasid, R. Neutrophils extracellular traps formation may serve as a biomarker for disease activity in oligoarticular juvenile idiopathic arthritis: a pilot study. Arthritis Research & Therapy. 2023; 25(1):135.

Smitherman, EA; Chahine, RA; Beukelman, T; Lewandowski, LB; Rahman, AKMF; Wenderfer, SE; Curtis, JR; Hersh, AO. Childhood-Onset Lupus Nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short-Term Kidney Status and Variation in Care. Arthritis Care and Research. 2023; 75(7):1553-1562.

De Benedetti, F; Grom, AA; Brogan, PA; Bracaglia, C; Pardeo, M; Marucci, G; Eleftheriou, D; Papadopoulou, C; Schulert, GS; Quartier, P; Asnaghi, V; Ballabio, M; Jacqmin, P; De Min, C. Efficacy and safety of emapalumab in macrophage activation syndrome. Annals of the Rheumatic Diseases. 2023; 82(6):857-865.

De Benedetti, F; Grom, A; Brogan, P; Bracaglia, C; Pardeo, M; Marucci, G; Eleftheriou, D; Papadopoulou, C; Schulert, G; Quartier, P; Asnaghi, V; Ballabio, M; Jacqmin, P; De Min, C. OP0166 LONG-TERM FOLLOW-UP OF PATIENTS ADMINISTERED EMAPALUMAB, AN ANTI–INTERFERON-Γ MONOCLONAL ANTIBODY, TO TREAT MACROPHAGE ACTIVATION SYNDROME (MAS) SECONDARY TO SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) Annals of the Rheumatic Diseases. 2023; 82:110-111.

Ruperto, N; Foeldvari, I; Alexeeva, E; Ayaz, NA; Schulert, G; Özen, S; Popov, A; Ramanan, A; Scott, C; Sozeri, B; Pricop, L; Lovell, DJ; Martini, A; Brunner, H. POS0278 EFFICACY AND SAFETY OF SECUKINUMAB IN JUVENILE IDIOPATHIC ARTHRITIS: INTERIM RESULTS FROM THE EXTENSION OF THE JUNIPERA TRIAL. Annals of the Rheumatic Diseases. 2023; 82:379-380.

Vega-Fernandez, P; Ting, TV; Mar, DA; Schapiro, AH; Deluna, MD; Saper, VE; Grom, AA; Schulert, GS; Fairchild, RM. Lung Ultrasound in Children With Systemic Juvenile Idiopathic Arthritis-Associated Interstitial Lung Disease. Arthritis Care and Research. 2023; 75(5):983-988.

Kuhn, KA; Stahly, A; Konig, MF; Carandang, K; Herndon, C; Backman, C; Callahan, LF; Schulert, G; Fraenkel, L; Ogdie, A. Impact of the COVID-19 Pandemic on Early Career Investigators in Rheumatology: Recommendations to Address Challenges to Early Research Careers. Arthritis Care and Research. 2023; 75(5):947-955.

Jhaveri, R; Webb, R; Razzaghi, H; Schuchard, J; Mejias, A; Bennett, TD; Jone, P-N; Thacker, D; Schulert, GS; Rogerson, C; Cogen, JD; Charles Bailey, L; Forrest, CB; Lee, GM; Rao, S. Can Multisystem Inflammatory Syndrome in Children Be Managed in the Outpatient Setting? An EHR-Based Cohort Study From the RECOVER Program. Journal of the Pediatric Infectious Diseases Society. 2023; 12(3):159-162.

Ringold, S; Dennos, AC; Kimura, Y; Beukelman, T; Shrader, P; Phillips, TA; Kohlheim, M; Schanberg, LE; Yeung, RSM; Horton, DB. Disease Recapture Rates After Medication Discontinuation and Flare in Juvenile Idiopathic Arthritis: An Observational Study Within the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis Care and Research. 2023; 75(4):715-723.

Inoue, N; Schulert, GS. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome. Arthritis Research & Therapy. 2023; 25(1):48.

Teoh, Z; Danziger-Isakov, L; Courter, JD; Frenck, RW; Grimley, MS; Marsh, RA; Paulsen, GC; Phillips, CL; Spearman, P; Chima, RS; Schulert, GS. Tocilizumab for Treatment of Children and Young Adults With Severe Acute COVID-19: Experience at a Quaternary-care Children's Hospital. Pediatric Infectious Disease Journal. 2023; 42(2):119-121.

Shiff, NJ; Shrader, P; Correll, CK; Dennos, A; Phillips, T; Beukelman, T. Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry. Rheumatology. 2023; 62(2):804-814.

Brunner, HI; Foeldvari, I; Alexeeva, E; Ayaz, NA; Calvo Penades, I; Kasapcopur, O; Chasnyk, VG; Hufnagel, M; Żuber, Z; Schulert, G; Pricop, L; Martini, A; Lovell, D; Ruperto, N. Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial. Annals of the Rheumatic Diseases. 2023; 82(1):154-160.

Macaraeg, M; Schulert, GS. Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis. RMD Open. 2023; 9(1).

Borgia, RE; Gurka, MJ; Filipp, SL; Elder, M; Cardel, M; Shiff, NJ. Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus. Clinical and Experimental Rheumatology. 2023; 41(1):186-194.

Smitherman, EA; Chahine, RA; Bitencourt, N; Rahman, AKMF; Lawson, EF; Chang, JC. Patient-Reported Outcomes Among Transition-Age Young Adults With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry. Journal of Rheumatology. 2023; 50(1):98-106.

Mansfield, LM; Lapidus, SK; Romero, SN; Moorthy, LN; Adler-Shohet, FC; Hollander, M; Cherian, J; Twilt, M; Lionetti, G; Mohan, S; Onel, KB; Dedeoglu, F; Gutierrez, MJ; Schulert, G. Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America. Frontiers in Pediatrics. 2023; 11:1240242.

Bahakel, H; Murphy, CR; Frenck, RW; Grimley, M; Phillips, C; Schulert, G; Spearman, P; Courter, JD; Paulsen, GC; Danziger-Isakov, LA. 1119. Covid-19 Mab Use in High-Risk Pediatric Patients. Open Forum Infectious Diseases. 2022; 9(Supplement_2):ofac492.958.

Bahakel, H; Murphy, C; Frenck, RW; Grimley, MS; Marsh, RA; Paulsen, GC; Haslam, DB; Phillips, CL; Courter, J; Spearman, P; Schulert, G; Danziger-Isakov, L. Single Site Experience of the use of Monoclonal Antibodies for the Treatment of COVID-19 in High-risk Pediatric and Young Adult Patients. Pediatric Infectious Disease Journal. 2022; 41(12):985-988.

Hahn, T; Daymont, C; Beukelman, T; Groh, B; Hays, K; Bingham, CA; Scalzi, L. Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatric Rheumatology. 2022; 20(1):107.

Son, MBF; Berbert, L; Young, C; Dallas, J; Newhams, M; Chen, S; Ardoin, SP; Basiaga, ML; Canny, SP; Crandall, H; Zambrano, LD; Campbell, AP; Patel, MM; Randolph, AG. Postdischarge Glucocorticoid Use and Clinical Outcomes of Multisystem Inflammatory Syndrome in Children. JAMA Network Open. 2022; 5(11):e2241622.

Schulert, GS. The Big Bad Wolf: Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus. Journal of Rheumatology. 2022; 49(10):1082-1084.

Neely, J; Ardalan, K; Huber, A; Kim, S. Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry. Pediatric Rheumatology. 2022; 20(1):50.

Chen, G; Deutsch, GH; Schulert, GS; Zheng, H; Jang, S; Trapnell, B; Lee, PY; Macaubas, C; Ho, K; Schneider, C; Goldbach-Mansky, R; Khatri, P; Mellins, ED; Canna, SW. Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis. Arthritis & Rheumatology. 2022; 74(7):1271-1283.

Henderson, LA; Canna, SW; Friedman, KG; Gorelik, M; Lapidus, SK; Bassiri, H; Behrens, EM; Kernan, KF; Schulert, GS; Seo, P; Mudano, AS; Turner, AS; Karp, DR; Mehta, JJ. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3. Arthritis & Rheumatology. 2022; 74(4):e1-e20.

Soulsby, WD; Balmuri, N; Cooley, V; Gerber, LM; Lawson, E; Goodman, S; Onel, K; Mehta, B. Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis. Pediatric Rheumatology. 2022; 20(1):18.

Verweyen, EL; Schulert, GS. Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA). Rheumatology. 2022; 61(3):926-935.